ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Washington, DC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Cancer
Neoplasm Metastasis
Ovarian Cancer
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck

Breast Cancer trials near Washington, DC, USA:

Niraparib + Dostarlimab In BRCA Mutated Breast Cancer

This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...

Active, not recruiting
Breast Cancer
Stage II Breast Cancer
Drug: Niraparib
Drug: Dostarlimab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Baltimore, Maryland, United States and 7 other locations

kinesin oral molecular degrader, administered as monotherapy or in combination with fulvestrant in adults with advanced or metastatic breast ...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Fulvestrant
Drug: BBI-940

Phase 1

Boundless Bio, Inc.

Fairfax, Virginia, United States and 7 other locations

radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify w...

Active, not recruiting
Breast Cancer Radiation
Device: Prosigna

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Baltimore, Maryland, United States and 5 other locations

dose levels of CLR 125 in patients with advanced triple negative breast cancer. The main questions the study aims to answer are:* W ...

Enrolling
Breast Cancer
Drug: CLR 125
Drug: Iopofosine I 131

Phase 1

Cellectar Biosciences

Glen Burnie, Maryland, United States and 2 other locations

standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...

Enrolling
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Capecitabine
Drug: PCS6422 and capecitabine

Phase 2

Processa Pharmaceuticals

Baltimore, Maryland, United States and 12 other locations

This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...

Active, not recruiting
Somatic Mutation Breast Cancer (BRCA1)
Somatic Mutation Breast Cancer (BRCA2)
Drug: Olaparib

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Baltimore, Maryland, United States and 19 other locations

works in treating HER2-negative (HER2-low or HER2-0) metastatic breast cancer.The names of the study drugs involved in this study a...

Enrolling
Breast Cancer
HER2-low Breast Cancer
Drug: Trastuzumab Deruxtecan
Drug: Datopotamab Deruxtecan

Phase 2

Ana C Garrido-Castro, MD

Washington D.C., District of Columbia, United States and 10 other locations

This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...

Active, not recruiting
Breast Cancer
Drug: Avelumab
Drug: Talazoparib

Phase 1, Phase 2

Georgetown University
Georgetown University

Washington D.C., District of Columbia, United States and 1 other location

Assessment of the safety and efficacy of HLD-0117 as monotherapy in patients with estrogen receptor positive (ER+) metastatic breast cancer...

Enrolling
Metastatic Breast Cancer
Drug: HLD-0117

Phase 1

Halda Therapeutics OpCo, Inc.

Fairfax, Virginia, United States and 2 other locations

triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...

Active, not recruiting
Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Carboplatin

Phase 2

Laura M. Spring, MD

Washington D.C., District of Columbia, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems